Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

NASDAQ:ASLE - Nasdaq - US00810F1066 - Common Stock - Currency: USD

5.86  -0.26 (-4.25%)

After market: 5.86 0 (0%)

Fundamental Rating

3

ASLE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. ASLE may be in some trouble as it scores bad on both profitability and health. ASLE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ASLE had positive earnings in the past year.
ASLE had a negative operating cash flow in the past year.
ASLE had positive earnings in 4 of the past 5 years.
In multiple years ASLE reported negative operating cash flow during the last 5 years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

ASLE has a Return On Assets of -0.88%. This is in the lower half of the industry: ASLE underperforms 64.62% of its industry peers.
With a Return On Equity value of -1.40%, ASLE is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROIC N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

In the last couple of years the Profit Margin of ASLE has declined.
ASLE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 29.07%, ASLE is in the better half of the industry, outperforming 67.69% of the companies in the same industry.
In the last couple of years the Gross Margin of ASLE has declined.
ASLE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.07%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

ASLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASLE has more shares outstanding
The number of shares outstanding for ASLE has been increased compared to 5 years ago.
Compared to 1 year ago, ASLE has about the same debt to assets ratio.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ASLE has an Altman-Z score of 1.97. This is not the best score and indicates that ASLE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.97, ASLE is not doing good in the industry: 72.31% of the companies in the same industry are doing better.
ASLE has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
ASLE has a better Debt to Equity ratio (0.33) than 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACC11.05%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ASLE has a Current Ratio of 4.54. This indicates that ASLE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.54, ASLE belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
ASLE has a Quick Ratio of 4.54. This is a bad value and indicates that ASLE is not financially healthy enough and could expect problems in meeting its short term obligations.
ASLE has a Quick ratio of 0.88. This is in the lower half of the industry: ASLE underperforms 70.77% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 0.88
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The earnings per share for ASLE have decreased strongly by -72.73% in the last year.
The Earnings Per Share has been growing by 22.36% on average over the past years. This is a very strong growth
The Revenue has decreased by -7.63% in the past year.
The Revenue has been growing slightly by 0.45% on average over the past years.
EPS 1Y (TTM)-72.73%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%-145.45%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%-27.35%

3.2 Future

ASLE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 74.93% yearly.
The Revenue is expected to grow by 8.59% on average over the next years. This is quite good.
EPS Next Y-35.58%
EPS Next 2Y74.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.45%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 195.33, the valuation of ASLE can be described as expensive.
63.08% of the companies in the same industry are cheaper than ASLE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.30, ASLE is valued quite expensively.
The Price/Forward Earnings ratio is 10.08, which indicates a very decent valuation of ASLE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ASLE indicates a rather cheap valuation: ASLE is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ASLE to the average of the S&P500 Index (21.76), we can say ASLE is valued rather cheaply.
Industry RankSector Rank
PE 195.33
Fwd PE 10.08
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ASLE.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.05
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ASLE's earnings are expected to grow with 74.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)8.74
EPS Next 2Y74.93%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (7/11/2025, 8:00:00 PM)

After market: 5.86 0 (0%)

5.86

-0.26 (-4.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners51.82%
Inst Owner Change0%
Ins Owners8.6%
Ins Owner Change-445.19%
Market Cap274.60M
Analysts80
Price Target7.65 (30.55%)
Short Float %4.23%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-79.82%
Min EPS beat(2)-157.67%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-83.78%
Min EPS beat(4)-157.67%
Max EPS beat(4)-1.96%
EPS beat(8)1
Avg EPS beat(8)-60.01%
EPS beat(12)3
Avg EPS beat(12)-40.33%
EPS beat(16)7
Avg EPS beat(16)10.17%
Revenue beat(2)1
Avg Revenue beat(2)-13.38%
Min Revenue beat(2)-27.97%
Max Revenue beat(2)1.22%
Revenue beat(4)1
Avg Revenue beat(4)-13.17%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)1.22%
Revenue beat(8)2
Avg Revenue beat(8)-16.53%
Revenue beat(12)3
Avg Revenue beat(12)-14.46%
Revenue beat(16)6
Avg Revenue beat(16)-7.92%
PT rev (1m)-6.25%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.78%
EPS NY rev (1m)-75.26%
EPS NY rev (3m)-73.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.45%
Valuation
Industry RankSector Rank
PE 195.33
Fwd PE 10.08
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.75
EV/EBITDA 25.05
EPS(TTM)0.03
EY0.51%
EPS(NY)0.58
Fwd EY9.92%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS6.84
BVpS8.67
TBVpS7.82
PEG (NY)N/A
PEG (5Y)8.74
Profitability
Industry RankSector Rank
ROA -0.88%
ROE -1.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.07%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score1
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 8.06
Cap/Depr 70.77%
Cap/Sales 4.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.54
Quick Ratio 0.88
Altman-Z 1.97
F-Score1
WACC11.05%
ROIC/WACCN/A
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.73%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%-145.45%
EPS Next Y-35.58%
EPS Next 2Y74.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%-27.35%
Revenue Next Year1.45%
Revenue Next 2Y8.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.55%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year323.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.1%
OCF growth 3Y-47.9%
OCF growth 5YN/A